Who
David Emerson Jorden
CEO/CFO
Company insider
Files Form 4 as: CEO/CFO, Cytomedix Inc Com New; Acting Chief Financial Officer, PLx Pharma; Acting Chief Financial Officer, Opexa Therapeutics; Director and 10% owner, ConnectOne Bancorp.
In numbers
- Trades disclosed
- 258
- Buys
- 122
- Sells
- 5
- Bought
- $2.3M
- Sold
- $714K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 19 Aug 2008
- Last trade
- 28 Aug 2026
- Last filed
- 31 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Aug 2026filed 31 Aug 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Bought | $8,6957,984 at $1.09 | filing |
| 28 Aug 2026filed 31 Aug 2026 | Nuo Therapeutics | SEC FORM 4 Bought | $8,7037,984 at $1.09 | filing |
| 28 Aug 2026filed 28 Aug 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code A | $8,6957,984 at $1.09 | filing |
| 28 Aug 2026filed 28 Aug 2026 | Nuo Therapeutics | SEC FORM 4 Code A | $8,7037,984 at $1.09 | filing |
| 27 Aug 2026filed 31 Aug 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Bought | $844789 at $1.07 | filing |
| 27 Aug 2026filed 31 Aug 2026 | Nuo Therapeutics | SEC FORM 4 Bought | $844789 at $1.07 | filing |
| 27 Aug 2026filed 28 Aug 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code A | $844789 at $1.07 | filing |
| 27 Aug 2026filed 28 Aug 2026 | Nuo Therapeutics | SEC FORM 4 Code A | $844789 at $1.07 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code M | $163K162,500 at $1.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code F | $163K160,892 at $1.01 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code M | —162,500 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code M | —162,500 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeutics | SEC FORM 4 Code M | $163K162,500 at $1.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | Nuo Therapeutics | SEC FORM 4 Code F | $163K160,892 at $1.01 | filing |
| 29 Jun 2026filed 2 Jul 2026 | Nuo Therapeuticsoption or derivative | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 29 Jun 2026filed 2 Jul 2026 | Cytomedix Inc Com Newoption or derivative · Medical Devices | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 5 Jun 2026filed 5 Jun 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code A | $15K13,245 at $1.10 | filing |
| 5 Jun 2026filed 5 Jun 2026 | Nuo Therapeutics | SEC FORM 4 Code A | $15K13,245 at $1.10 | filing |
| 1 Jan 2026filed 5 Jan 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code M | $50K125,000 at $0.40 | filing |
| 1 Jan 2026filed 5 Jan 2026 | Cytomedix Inc Com NewMedical Devices | SEC FORM 4 Code F | $50K25,381 at $1.97 | filing |
News
Connectone Bancorp, Inc. Announces Third Quarter 2026 Results Including Balance Sheet Restructuring and RepositioningCNOB · manilatimes.net · 22 Oct 2026ConnectOne Bancorp (NASDAQ:CNOB) versus Triumph Financial (NYSE:TFIN) Critical ContrastCNOB · dailypolitical.com · 20 Oct 2026Critical Survey: ConnectOne Bancorp (NASDAQ:CNOB) versus Triumph Financial (NYSE:TFIN)CNOB · themarketsdaily.com · 13 Oct 2026
0 headlines in the last 90 days name David Emerson Jorden; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.